Invokamet Xr Tablet, Film Coated, Extended Release
Pricing Report NDC 50458-942-01

Current NADAC: $9.56119 per EA · Effective Sep 23, 2026 · Est. package price $573.67 (60 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Invokamet Xr (NDC 50458-942-01) is $9.56119 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Janssen Pharmaceuticals, Inc., this medication is distributed in a 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.56119
Per EA

Effective Date
Sep 23, 2026
Billable Units
60 EA
Estimated Package Price
$573.67
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2017, the NADAC wholesale price for (NDC ) has moved within a range of $6.84019 to $9.61765 per EA. Over this 9 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$6.8402 - $9.6177
Market Volatility
40.61% Variance
Latest Trend
No Change

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $9.56119 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $9.56124 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $9.53732 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $9.56124 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $9.56646 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $9.56469 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $9.56469 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $9.56890 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $9.56692 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.57278 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $9.56783 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $9.56783 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026